2. Academic Validation
  3. Structure of human spermine oxidase in complex with a highly selective allosteric inhibitor

Structure of human spermine oxidase in complex with a highly selective allosteric inhibitor

  • Commun Biol. 2022 Aug 5;5(1):787. doi: 10.1038/s42003-022-03735-9.
Elsie Diaz  # 1,  Suraj Adhikary  # 1,  Armand W J W Tepper  # 2,  Daniel Riley 1,  Rodrigo Ortiz-Meoz 1,  Daniel Krosky 1,  Christophe Buyck 3,  Carolina Martinez Lamenca 3,  Josep Llaveria 4,  Lichao Fang 5,  Jay H Kalin 1,  Vincent N A Klaren 2,  Shorouk Fahmy 2,  Paul L Shaffer 1,  Robert Kirkpatrick 1,  Rodrigo J Carbajo 4,  Maren Thomsen 6,  Antonietta Impagliazzo 7 8
Affiliations

Affiliations

  • 1 Janssen Research & Development, Welsh & McKean Roads, Spring House, PA, 19477-0776, USA.
  • 2 Janssen Vaccine and Prevention, Archimedesweg 4-6, 2301, CA, Leiden, The Netherlands.
  • 3 Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.
  • 4 Janssen Research & Development, Janssen-Cilag, Discovery Chemistry S.A. Río Jarama, 75A, 45007, Toledo, Spain.
  • 5 Janssen Research & Development Center Medicinal Chemistry, Shanghai, 201210, China.
  • 6 Proteros biostructures GmbH Bunsenstr 7a, D-82152, Martinsried, Germany.
  • 7 Janssen Vaccine and Prevention, Archimedesweg 4-6, 2301, CA, Leiden, The Netherlands. anim@genmab.com.
  • 8 Genmab B.V. Uppsalalaan 15, 3584, CT, Utrecht, The Netherlands. anim@genmab.com.
  • # Contributed equally.
PMID: 35931745 DOI: 10.1038/s42003-022-03735-9
Abstract

Human spermine oxidase (hSMOX) plays a central role in polyamine catabolism. Due to its association with several pathological processes, including inflammation and Cancer, hSMOX has garnered interest as a possible therapeutic target. Therefore, determination of the structure of hSMOX is an important step to enable drug discovery and validate hSMOX as a drug target. Using insights from hydrogen/deuterium exchange mass spectrometry (HDX-MS), we engineered a hSMOX construct to obtain the first crystal structure of hSMOX bound to the known polyamine oxidase inhibitor MDL72527 at 2.4 Å resolution. While the overall fold of hSMOX is similar to its homolog, murine N1-acetylpolyamine oxidase (mPAOX), the two structures contain significant differences, notably in their substrate-binding domains and active site pockets. Subsequently, we employed a sensitive biochemical assay to conduct a high-throughput screen that identified a potent and selective hSMOX inhibitor, JNJ-1289. The co-crystal structure of hSMOX with JNJ-1289 was determined at 2.1 Å resolution, revealing that JNJ-1289 binds to an allosteric site, providing JNJ-1289 with a high degree of selectivity towards hSMOX. These results provide crucial insights into understanding the substrate specificity and enzymatic mechanism of hSMOX, and for the design of highly selective inhibitors.

Figures
Products